More insights into the immunosuppressive potential of tumor exosomes - PubMed (original) (raw)

Editorial

More insights into the immunosuppressive potential of tumor exosomes

Veronica Huber et al. J Transl Med. 2008.

No abstract available

PubMed Disclaimer

Comment on

• Exosomes as a tumor immune escape mechanism: possible therapeutic implications.
  Ichim TE, Zhong Z, Kaushal S, Zheng X, Ren X, Hao X, Joyce JA, Hanley HH, Riordan NH, Koropatnick J, Bogin V, Minev BR, Min WP, Tullis RH. Ichim TE, et al. J Transl Med. 2008 Jul 22;6:37. doi: 10.1186/1479-5876-6-37. J Transl Med. 2008. PMID: 18644158 Free PMC article.

Similar articles

• Exosomes and tumor-mediated immune suppression.
  Whiteside TL. Whiteside TL. J Clin Invest. 2016 Apr 1;126(4):1216-23. doi: 10.1172/JCI81136. Epub 2016 Feb 29. J Clin Invest. 2016. PMID: 26927673 Free PMC article. Review.
• Tumor-released microvesicles as vehicles of immunosuppression.
  Valenti R, Huber V, Iero M, Filipazzi P, Parmiani G, Rivoltini L. Valenti R, et al. Cancer Res. 2007 Apr 1;67(7):2912-5. doi: 10.1158/0008-5472.CAN-07-0520. Cancer Res. 2007. PMID: 17409393 Review.
• MHC independent anti-tumor immune responses induced by Hsp70-enriched exosomes generate tumor regression in murine models.
  Cho JA, Lee YS, Kim SH, Ko JK, Kim CW. Cho JA, et al. Cancer Lett. 2009 Mar 18;275(2):256-65. doi: 10.1016/j.canlet.2008.10.021. Epub 2008 Nov 25. Cancer Lett. 2009. PMID: 19036499
• Human placenta expresses and secretes NKG2D ligands via exosomes that down-modulate the cognate receptor expression: evidence for immunosuppressive function.
  Hedlund M, Stenqvist AC, Nagaeva O, Kjellberg L, Wulff M, Baranov V, Mincheva-Nilsson L. Hedlund M, et al. J Immunol. 2009 Jul 1;183(1):340-51. doi: 10.4049/jimmunol.0803477. J Immunol. 2009. PMID: 19542445
• Systemic presence and tumor-growth promoting effect of ovarian carcinoma released exosomes.
  Keller S, König AK, Marmé F, Runz S, Wolterink S, Koensgen D, Mustea A, Sehouli J, Altevogt P. Keller S, et al. Cancer Lett. 2009 Jun 8;278(1):73-81. doi: 10.1016/j.canlet.2008.12.028. Epub 2009 Feb 1. Cancer Lett. 2009. PMID: 19188015

Cited by

• Exosomes/microvesicles: mediators of cancer-associated immunosuppressive microenvironments.
  Taylor DD, Gercel-Taylor C. Taylor DD, et al. Semin Immunopathol. 2011 Sep;33(5):441-54. doi: 10.1007/s00281-010-0234-8. Epub 2011 Jun 19. Semin Immunopathol. 2011. PMID: 21688197 Review.
• Biology, Therapy and Implications of Tumor Exosomes in the Progression of Melanoma.
  Isola AL, Eddy K, Chen S. Isola AL, et al. Cancers (Basel). 2016 Dec 9;8(12):110. doi: 10.3390/cancers8120110. Cancers (Basel). 2016. PMID: 27941674 Free PMC article. Review.
• Exosomes: The Link between GPCR Activation and Metastatic Potential?
  Isola AL, Chen S. Isola AL, et al. Front Genet. 2016 Apr 8;7:56. doi: 10.3389/fgene.2016.00056. eCollection 2016. Front Genet. 2016. PMID: 27092178 Free PMC article. Review.
• The paradoxical patterns of expression of indoleamine 2,3-dioxygenase in colon cancer.
  Gao YF, Peng RQ, Li J, Ding Y, Zhang X, Wu XJ, Pan ZZ, Wan DS, Zeng YX, Zhang XS. Gao YF, et al. J Transl Med. 2009 Aug 20;7:71. doi: 10.1186/1479-5876-7-71. J Transl Med. 2009. PMID: 19695096 Free PMC article.
• Immune modulation of T-cell and NK (natural killer) cell activities by TEXs (tumour-derived exosomes).
  Whiteside TL. Whiteside TL. Biochem Soc Trans. 2013 Feb 1;41(1):245-51. doi: 10.1042/BST20120265. Biochem Soc Trans. 2013. PMID: 23356291 Free PMC article. Review.

References

1. 1. Ichim TE, Zhong Z, Kaushal S, Zheng X, Ren X, Hao X, Joyce JA, Hanley HH, Riordan NH, Koropatnick J, Bogin V, Minev BR, Min WP, Tullis RH. Exosomes as a tumor immune escape mechanism: possible therapeutic implications. J Transl Med. 2008;6:37. - PMC - PubMed
2. 1. Valenti R, Huber V, Iero M, Filipazzi P, Parmiani G, Rivoltini L. Tumor-released microvesicles as vehicles of immunosuppression. Cancer Res. 2007;67:2912–2915. - PubMed
3. 1. Iero M, Valenti R, Huber V, Filipazzi P, Parmiani G, Fais S, Rivoltini L. Tumour-released exosomes and their implications in cancer immunity. Cell Death Differ. 2008;15:80–88. - PubMed
4. 1. Marincola FM, Jaffee EM, Hicklin DJ, Ferrone S. Escape of human solid tumors from T-cell recognition: molecular mechanisms and functional significance. Adv Immunol. 2000;74:181–273. - PubMed
5. 1. Rivoltini L, Canese P, Huber V, Iero M, Pilla L, Valenti R, Fais S, Lozupone F, Casati C, Castelli C, Parmiani G. Escape strategies and reasons for failure in the interaction between tumour cells and the immune system: how can we tilt the balance towards immune-mediated cancer control? Expert Opin Biol Ther. 2005;5:463–476. - PubMed

Publication types

MeSH terms

LinkOut - more resources

• Full Text Sources

  • BioMed Central
  • Europe PubMed Central
  • PubMed Central

• Other Literature Sources

  • The Lens - Patent Citations Database